What regions does the CRISPR & Cas9 market report cover?

The report covers the CRISPR & Cas9 market across Global, including detailed regional breakdowns, forecasts, and competitive analysis.

CRISPR & Cas9 Growth Drivers & Forecast Analysis 2033

CRISPR & Cas9 by Type (/> Genome Editing, Genetic Engineering, gRNA Database/Gene Librar, CRISPR Plasmid, Human Stem Cells, Genetically Modified Organisms/Crops, Cell Line Engineering), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 121

Forecast Period: 2026 - 2033

Market Size: $3200 million

CAGR: 16.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Pages: 121

Forecast Period: 2026 - 2033

Market Size: $3200 million

CAGR: 16.2%

Historical Range: 2020 - 2025

Sep 9, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

11 items

1. Executive Summary

2. CRISPR & Cas9 Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global CRISPR & Cas9 Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global CRISPR & Cas9 Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.1. /> Genome Editing

6.1.2. Genetic Engineering

6.1.3. gRNA Database/Gene Librar

6.1.4. CRISPR Plasmid

6.1.5. Human Stem Cells

6.1.6. Genetically Modified Organisms/Crops

6.1.7. Cell Line Engineering

6.2. Global CRISPR & Cas9 Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global CRISPR & Cas9 Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global CRISPR & Cas9 Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

8. Global CRISPR & Cas9 Market Competition by Key Manufacturers

8.1. Global CRISPR & Cas9 Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global CRISPR & Cas9: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Caribou Biosciences

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Integrated DNA Technologies(IDT)

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. CRISPR Therapeutics

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Merck

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Mirus Bio

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Editas Medicine

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Takara Bio

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Thermo Fisher Scientific

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Horizon Discovery Group

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Intellia Therapeutics

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Agilent Technologies

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Cellecta

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. GenScript

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. GeneCopoeia

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Synthego

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

20 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global CRISPR & Cas9 Market

Figure 4: Global CRISPR & Cas9 Market: Drivers

Figure 5: Global CRISPR & Cas9 Market: Challenges

Figure 6: Global CRISPR & Cas9 Market: Trends

Figure 7: Global CRISPR & Cas9 Market: Opportunity

Figure 8: Global CRISPR & Cas9 Market: Restraint

Figure 9: Global CRISPR & Cas9 Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global CRISPR & Cas9 Market Value (USD Million) By Region

Figure 13: Global CRISPR & Cas9 Market Share (%) By: Regions (2024)

Figure 14: Top 5 Manufacturers

Figure 15: Top 3 Manufacturers

Figure 16: Global Market Value (USD Million) (2025-2032) By Type

Figure 17: Global Market Share (%) By Type (2032)

Figure 18: Global CRISPR & Cas9 Market Value (USD Million) By Region

Figure 19: Global CRISPR & Cas9 Market Share (%) By: Regions (2032)

Figure 20: Data Triangulation

List of Tables

68 items

Table 1: Market Segmentation Analysis

Table 2: Global CRISPR & Cas9 Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global CRISPR & Cas9 Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 4: Global Market Value (USD Million) (2020-2024) By Type

Table 5: Global Market Share (%) By Type (2024)

Table 6: Global CRISPR & Cas9 Market Value (USD Million) By Region

Table 7: Global CRISPR & Cas9 Market Share (%) By Region

Table 8: North America Market Value (USD Million) (2020-2024) By Country

Table 9: North America Market Value (USD Million) (2020-2024) By Type

Table 10: Europe Market Value (USD Million) (2020-2024) By Country

Table 11: Europe Market Value (USD Million) (2020-2024) By Type

Table 12: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 13: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 14: South America Market Value (USD Million) (2020-2024) By Country

Table 15: South America Market Value (USD Million) (2020-2024) By Type

Table 16: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 17: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 18: Global CRISPR & Cas9 Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 19: Global CRISPR & Cas9 Market: Profiled Players Head Office And Area Served

Table 20: Key Players Global CRISPR & Cas9 Market:

Table 21: Mergers & Acquisitions, Expansion Plans

Table 22: Caribou Biosciences Basic Information And Sales Area

Table 23: Caribou Biosciences. Products Portfolio

Table 24: Integrated DNA Technologies(IDT) Basic Information And Sales Area

Table 25: Integrated DNA Technologies(IDT). Products Portfolio

Table 26: CRISPR Therapeutics Basic Information And Sales Area

Table 27: CRISPR Therapeutics. Products Portfolio

Table 28: Merck Basic Information And Sales Area

Table 29: Merck. Products Portfolio

Table 30: Mirus Bio Basic Information And Sales Area

Table 31: Mirus Bio. Products Portfolio

Table 32: Editas Medicine Basic Information And Sales Area

Table 33: Editas Medicine. Products Portfolio

Table 34: Takara Bio Basic Information And Sales Area

Table 35: Takara Bio. Products Portfolio

Table 36: Thermo Fisher Scientific Basic Information And Sales Area

Table 37: Thermo Fisher Scientific. Products Portfolio

Table 38: Horizon Discovery Group Basic Information And Sales Area

Table 39: Horizon Discovery Group. Products Portfolio

Table 40: Intellia Therapeutics Basic Information And Sales Area

Table 41: Intellia Therapeutics. Products Portfolio

Table 42: Agilent Technologies Basic Information And Sales Area

Table 43: Agilent Technologies. Products Portfolio

Table 44: Cellecta Basic Information And Sales Area

Table 45: Cellecta. Products Portfolio

Table 46: GenScript Basic Information And Sales Area

Table 47: GenScript. Products Portfolio

Table 48: GeneCopoeia Basic Information And Sales Area

Table 49: GeneCopoeia. Products Portfolio

Table 50: Synthego Basic Information And Sales Area

Table 51: Synthego. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Type

Table 53: Global Market Share (%) By Type (2032)

Table 54: Global CRISPR & Cas9 Market Value (USD Million) By Region

Table 55: Global CRISPR & Cas9 Market Share (%) By Region (2025-2032)

Table 56: North America Market Value (USD Million) (2025-2032) By Country

Table 57: North America Market Value (USD Million) (2025-2032) By Type

Table 58: Europe Market Value (USD Million) (2025-2032) By Country

Table 59: Europe Market Value (USD Million) (2025-2032) By Type

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 61: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 62: South America Market Value (USD Million) (2025-2032) By Country

Table 63: South America Market Value (USD Million) (2025-2032) By Type

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 66: Research Programs/Design For This Report

Table 67: Key Data Information From Secondary Sources

Table 68: Key Data Information From Primary Sources

FAQs

1. What is the projected Compound Annual Growth Rate (CAGR) of the CRISPR & Cas9?

The projected CAGR is approximately 16.2.

2. Which companies are prominent players in the CRISPR & Cas9?

Key companies in the market include Caribou Biosciences, Integrated DNA Technologies(IDT), CRISPR Therapeutics, Merck, Mirus Bio, Editas Medicine, Takara Bio, Thermo Fisher Scientific, Horizon Discovery Group, Intellia Therapeutics, Agilent Technologies, Cellecta, GenScript, GeneCopoeia, Synthego.

3. What are the main segments of the CRISPR & Cas9?

The market segments include Type, Application.

4. Can you provide details about the market size?

The market size is estimated to be 3200

5. What are some drivers contributing to market growth?

Increasing Demand for Various Applications to Aid Market Growth.

6. What are the notable trends driving market growth?

Increasing Demand for Various Applications to Aid Market Growth.

7. Are there any restraints impacting market growth?

Increasing Demand for Various Applications to Aid Market Growth.

8. Can you provide examples of recent developments in the market?

Recent developments data is not available.

9. What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4480.00, USD 6720.00, and USD 8960.00 respectively.

10. Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in 3200.

11. Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "CRISPR & Cas9," which aids in identifying and referencing the specific market segment covered.

12. How do I determine which pricing option suits my needs best?

The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.

13. Are there any additional resources or data provided in the CRISPR & Cas9 report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided with the report for further details.

14. How can I stay updated on further developments or reports in the CRISPR & Cas9?

To stay informed about further developments, trends, and reports in the CRISPR & Cas9, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.

Contact for Full Report

Loading report content...

Table of Contents